ARGX Competitors & Alternatives
Compare argenx NV ADR with similar stocks in the same industry
Biotechnology
ARGX
Main Stock$807.80
Tradestie Score
55
Market Cap
$46.96B
P/E Ratio
36.1
Revenue Growth
0.6%
Analyst Upside
+27.8%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
REGN
Regeneron Pharmaceuticals Inc
|
$717.97
|
$63.59B | 17.4 | 59 | Compare |
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
$293.75
|
$60.38B | 71.4 | 54 | Compare |
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$303.70
|
$36.81B | 71.4 | 59 | Compare |
|
INSM
Insmed, Inc.
|
$117.75
|
$31.13B | - | 45 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$92.11
|
$24.57B | - | 54 | Compare |
|
GMAB
Genmab A/S ADS
|
$27.01
|
$19.56B | 20.7 | 50 | Compare |
|
INCY
Incyte Genomics Inc
|
$97.90
|
$16.93B | 14.2 | 64 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$53.26
|
$15.70B | 27.2 | 67 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$18.06
|
$15.22B | - | 49 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$244.88
|
$12.36B | 26.7 | 59 | Compare |
More ARGX Analysis
Data updated: May 14, 2026 | Industry: Biotechnology (SIC 2836)
227 stocks in this industry